Joseph M. Miano, Ph.D.

Contact Information

Phone Numbers

Administrative: (585) 276-7697

Office: (585) 276-7703

Fax: (585) 276-9829

Locations

Medical College of Georgia at Augusta University
1560 Laney Walker Blvd
Augusta, GA 30912

Faculty Appointments

Adjunct Professor - Department of Medicine , Aab Cardiovascular Research Institute (SMD)

Biography

Dr. Joseph Miano grew up in Chili, a suburb of Rochester, New York. He graduated from Gates-Chili High School in 1980 and, following one year of playing junior hockey in Western New York and Southern Ontario, he attended SUNY Cortland and graduated in 1986 with dual degrees in Biology and Physical Education (Exercise Science). His undergraduate research, performed in 1983-86 under the tutelage of David Berger and Jim Starzec, investigated the effects of psychological stress or voluntary exercise on fatty streak formation in the aorta of spontaneously hypertensive rats. His PhD research, in Experimental Pathology at New York Medical College under the mentorship of Michael Stemerman, involved the identification of genes rapidly turned on following experimental balloon angioplasty. His post-doctoral training was done with Eric Olson at the MD Anderson Cancer Center in Houston Texas where he cloned and characterized several smooth muscle-restricted promoters and initiated the study of retinoids in the blood vessel wall. He was recruited to the University of Rochester in 1999 following a three year appointment at the Medical College of Wisconsin where he developed a passion for the human genome. A major research aim in the Miano Lab has been to decipher the small snippets of codes in our genome that dictate how genes involved in cardiovascular disease are either turned up or down. Much like a thermostat controlling the heat in a home, cells normally have exquisite control over the level of gene activity. Diseases of the heart and blood vessels occur when this 'geneostat' control runs awry. Thus, identifying and understanding how certain genetic codes control genes turning on and off is a foundation for developing novel methods of predicting and perhaps treating various diseases of the body. Dr. Miano's lab was among the first wave of labs in 2013 to exploit the revolutionary CRISPR genome editing technology for purposes of altering the mouse genome and, within a year, the lab generated the first CRISPR animal model carrying subtle mutations in a control element that turns on a gene (Cnn1). To date, Dr. Miano has published over 100 research papers that focus on the control of gene expression in smooth muscle cells of the blood vessel wall. He previously served as Associate Editor of ATVB and Consulting Editor of Circulation Research. He is a Fellow of the American Heart Association and a member of the Vascular Cell and Molecular Biology Study Section at NIH.

Links of interest for the lay public:

Research Gate https://www.researchgate.net/home

Professional Background

Dr. Joseph M. Miano received his Ph.D. in Experimental Pathology from New York Medical College in 1992. His post-doctoral training was done in Eric Olson's laboratory at the University of Texas M.D. Anderson Cancer Center where he cloned and characterized several smooth muscle-restricted promoters and initiated the study of retinoids in the vessel wall. Prior to his appointment at the U of R, Dr. Miano was an Assistant Professor in the Department of Physiology at the Medical College of Wisconsin where his genomics interests were developed and cultivated through collaborative work with Howard Jacob's lab. Dr. Miano served as an editorial board member for several journals and was Associate Editor of ATVB and a Consulting Editor for Circulation Research. He is a Fellow of the American Heart Association and a member of the Vascular Cell and Molecular Biology Study Section at NIH.

Links of interest for the lay public:

Research Gate https://www.researchgate.net/home

https://www.researchgate.net/about

Revolutionary CRISPR Genome Editing

https://www.youtube.com/watch?v=jAhjPd4uNFY&t=22s

Research

The human genome is replete with functional information, including millions of transcription factor binding sites (TFBS) that bind some 1400 transcription factors and several classes of non-coding RNA genes, particularly the rapidly growing class of long non-coding RNA (lncRNA). Thus, the long-held notion that the human genome is made up largely of "junk DNA" has been debunked and a new era has emerged to elucidate the functionality of the non-protein coding genome which comprises 98% of our blueprint of life.

Though the ENCODE Consortium and other big genome projects have been a magnificent kick-start for this new endeavor, much remains to be learned across the ~250 distinct cell types that make up the human body, especially under stress conditions that simulate disease processes. Accordingly, research in the Miano Lab is focused broadly on the vascular smooth muscle cell (VSMC) and how this cell type's differentiation program is controlled through both key TFBS and lncRNAs. Much of the work revolves around a DNA-binding transcription factor called serum response factor (SRF), its TFBS known as a CArG box, and an SRF cofactor called Myocardin (MYOCD), which his lab first showed to be a potent stimulus for the VSMC differentiation program. Current funded projects involve the study of a protein-coding gene (AKAP12A) that is a direct target of the SRF-Myocardin switch; the regulation of MYOCD and its role in vascular diseases; and the elucidation of the CArGome (all functional CArG boxes in the genome).

The latter project is also aimed to gain insight into CArG-SNPs that may be linked to human diseases. Since the vast majority of the >3.6 million CArG boxes punctuating the human genome fall in intergenic or intronic sequence space where "pervasive transcription" is known to occur, the lab initiated several screens to define known and novel lncRNAs in human VSMC. A major focus of the lab is obtaining functional insight into a novel lncRNA (SENCR) enriched in vascular cells as well as a number of known and novel lncRNAs that are regulated by SRF and/or MYOCD. The project pipeline involves a systematic series of experiments to define expression of lncRNAs in human tissues and cell lines; elucidating full length transcripts by RACE; defining spatial localization of lncRNAs by RNA-FISH; ascertaining potential regulatory sequences within lncRNAs (e.g., microRNA binding site, TFBS, etc); defining lncRNA promoters and the signaling molecules that converge upon regulatory sequences therein; defining altered transcriptomes by RNA-seq following loss-of-function with dicer substrate siRNAs directed to several regions of a lncRNA; and lncRNA interaction studies with other RNAs or proteins to begin understanding mechanistic aspects of lncRNAs. The Miano Lab utilizes state-of-the-art tools in genetics (e.g., HDR-mediated genome editing with CRISPR-Cas9), genomics, bioinformatics, and molecular biology to elucidate regulatory element and lncRNA biology in experimental and clinically relevant settings.

Credentials

Education

1986
BS | SUNY Coll at Cortland
Biology

1988
MS | New York Medical College
Experimental Pathology

1992
PhD | New York Medical College
Experimental Pathology

Post-doctoral Training & Residency

1992 - 1995
Department of Biochemistry & Molecular Biology, University of Texas, MD Anderson Cancer Center, Houston Texas. (Eric Olson, Mentor)

Awards

2014
Vascular Biology Special Recognition Award

2003 - 2007
Established Investigator Award American Heart Association

2003
Who's Who in Medicine and Healthcare

1997
Manitowoc Heart-A-Rama Research for Life
Sponsor: American Heart Association (AHA)
Location: Wisconsin Affiliate

1993
Post-Doctoral National Research Service, Smooth Muscle Cell Differentiation
Sponsor: National Institutes of Health
Location: MD Anderson Cancer Center

1992
Helen S. Page Memorial Ph.D.

VIEW ALL

Publications

Journal Articles

1/19/2023
Rambout X, Cho H, Blanc R, Lyu Q, Miano JM, Chakkalakal JV, Nelson GM, Yalamanchili HK, Adelman K, Maquat LE. "PGC-1? senses the CBC of pre-mRNA to dictate the fate of promoter-proximally paused RNAPII." Molecular cell.. 2023 Jan 19; 83(2):186-202.e11.

1/9/2023
Zhang W, Zhao J, Deng L, Ishimwe N, Pauli J, Wu W, Shan S, Kempf W, Ballantyne MD, Kim D, Lyu Q, Bennett M, Rodor J, Turner AW, Lu YW, Gao P, Choi M, Warthi G, Kim HW, Barroso MM, Bryant WB, Miller CL, Weintraub NL, Maegdefessel L, Miano JM, Baker AH, Long X. "is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10." bioRxiv : the preprint server for biology.. 2023 Jan 9; Epub 2023 Jan 09.

11/2022
Warthi G, Faulkner JL, Doja J, Ghanam AR, Gao P, Yang AC, Slivano OJ, Barris CT, Kress TC, Zawieja SD, Griffin SH, Xie X, Ashworth A, Christie CK, Bryant WB, Kumar A, Davis MJ, Long X, Gan L, de Chantemèle EJB, Lyu Q, Miano JM. "Generation and Comparative Analysis of an Mouse with Preferential Activity in Vascular Smooth Muscle Cells." . 2022 Nov; 1(11):1084-1100. Epub 2022 Nov 11.

Books & Chapters

2012
Chapter Title: Muscle: Fundamental Biology and Mechanisms of Disease
Book Title: Vascular smooth muscle cell phenotypic adaptation
Author List: Miano JM
Edited By: Hill, J.A. and Olson, E.N
Published By: Academic Press 2012

1999
Chapter Title: Retinoids and interferons as antiangiogenic cancer drugs
Book Title: Antiangiogenic Agents in Cancer
Author List: Clifford, J.L., Miano, J.M., and Lippman, S.M
Edited By: Teicher, B.A.
Published By: Humana Press 1999

1999
Chapter Title: Radiation hybrid (RH) mapping of human smooth muscle-restricted genes.
Book Title: Molecular Biology of Vascular Disease.
Author List: Miano, J.M.*, Garcia, E. and Krahe, R.
Edited By: Baker, A.H.
Published By: Humana Press 1999

VIEW ALL PUBLICATIONS